BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 8,440.00
+140.00 (1.69%)
At close: Aug 11, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 73.39 billion as of August 11, 2026. Its market cap has decreased by -55.77% in one year.
Market Cap
73.39B
Enterprise Value
19.98B
Revenue
18.85B
Ranking
n/a
PE Ratio
11.62
Stock Price
8,440.00
ChartMarket Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 73.39B, a decrease of -61.98%. That is a compound annual growth rate of -19.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 73.39B | -46.58% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Choong Ang Vaccine Laboratory | 86.64B |
| EyeGene | 84.30B |
| SunBio,Inc. | 81.70B |
| CTCBIO | 80.45B |
| IMGT Co.,Ltd. | 70.22B |
| AriBioLab | 69.89B |
| PanGen Biotech | 69.87B |
| QuadMedicine | 69.81B |